Perioperative β blockade

The Lancet

Volumn 372, Issue 9644, 2008, Pages 1147-1148

  Bangalore, Sripal ^a   Gluud, Christian ^a   Wetterslev, Jorn ^a   Messerli, Franz H ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL;

ANGINA PECTORIS; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG MEGADOSE; HEART INFARCTION; HUMAN; HYPOTENSION; LETTER; PATIENT SELECTION; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAMPLE SIZE; STRESS ECHOCARDIOGRAPHY; SURGICAL MORTALITY; SURGICAL RISK;

EID: 52949104707     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61475-0     Document Type: Letter

References (5)

1. Fleisher L.A., and Poldermans D. Perioperative β blockade: where do we go from here?. Lancet 371 (2008) 1813-1814
2. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
3. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
4. Brady A.R., Gibbs J.S., Greenhalgh R.M., Powell J.T., and Sydes M.R. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
5. Juul A.B., Wetterslev J., Gluud C., et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 (2006) 1482